Innovative Coffee Ingredient for Drinking New and Healthy

• Customization: Available
• Storage Method: Normal
• Shelf Life: >12 Months
• Model NO.: LP-KFY04
• Smell: Addible
• Appearance: Dry Powder
• Cfu Density: Adjustable
• Transport Package: Plastic Bagged or Canister
• Specification: TBC
• Trademark: N
• Origin: China
• HS Code: 21069090
• Production Capacity: 500, 000p/M

Product Description

Introduction
Lactobacillus plantarum KFY04, was isolated from Xinjiang yogurt, and it was used to intervene in obese mice maintained on a 45% fat diet, and we compared its effects to those of a commercial strain, LDSB, and L-carnitine. The results showed that the LP-KFY04 intervention mice gained weight more slowly and had lower liver, epididymal adipose, and perirenal adipose tissue indices when compared to the other high-fat groups. Moreover, the LP-KFY04 can reduce the formation of fat vacuoles in the liver, while also reducing adipocyte differentiation and volume, and LP-KFY04 groups had the lowest liver and serum AST, ALT, TG, and TC levels and lowest serum LDL-C and highest HDL-C levels among the groups maintained on a high-fat diet. LP-KFY04 was also shown to mitigate obesity-associated oxidative damage and inflammatory responses. Additionally, quantitative real-time PCR and western blot analysis examining liver and adipose tissue expression of PPAR-α, CYP7A1, CPT1, and LPL showed an increased expression in the LP-KFY04 groups while decreased expression levels of PPAR-γ and C/EBPα relative to the other high-fat diet groups. These results show that of the different interventions, LP-KFY04 was the most effective at mitigating the effects of obesity than LDSB and L-carnitine. The results confirmed that LP-KEY04 has better anti-obesity, anti-oxidative, and anti-inflammatory effects than current fermentation strains. It indicates LP-KFY04 is a fermentation strain with potential practical value and high functionality, and it shows that a fermentation strain should not only have good fermentation performance, but, more importantly, it must provide more functionality on the basis of fermentation.Effect of Lactobacillus plantarum on body weight gain, liver weight, adipose tissue in HFD-fed mice. (A) Body weight from 1 to 11 wk. (B) Body weight. (C) Liver weight. (D) Epididymal adipose tissue weight. (E) Perirenal adipose tissue weight at 11 wk. (F), (G), (H) HE staining of epididymal adipose tissue of NCD, HFD, and HFD-HT groups at 400×, respectively. (I) Epididymal adipose tissue size. N = 10 mice for each group. Statistical analyses were performed using one-way ANOVA followed by Tukey's test, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Effect of Lactobacillus plantarum on inflammatory associated factors in serum and SCFAs in feces. (A) LPS. (B) TNFα. (C) IL-1β. (D) IL-6. (E) Acetic acid (F) Propionic acid. (G) Butyric acid. (H) Isobutyric acid. n = 10 for inflammatory factors (A-D), n = 5 mice for SCFAs. Statistical analyses were performed using one-way ANOVA followed by Tukey's test. ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.
Preventive effect of Lactobacillus plantarum HT121 on glucose tolerance. (A) GTT. (B) P values of different time points. (C) Blood glucose concentrations of 120 m. n = 5 mice for NCD group, n = 10 mice for the other two groups. Statistical analyses were performed using one-way ANOVA followed by Tukey's test, ∗ P < 0.05, ∗∗ P < 0.01, ∗∗∗ P < 0.001.
       We are also an enterprise focusing on the R&D, production and sales of freeze-dried coffee powder, functional coffee, probiotic snack food, and high-end food ingredients.
The company relies on advanced microbial fermentation technology and freeze-drying technology to carry out deep processing of coffee. With rich experience in biotechnology and functional food formulation, we provide customers with scientific and effective product solutions.
The company's products have been exported to the United States, Europe and Australia and other countries and regions, and more than 20 patents have been declared and more than 10 have been authorized. The company adheres to independent innovation, consolidates the foundation of scientific research, is based on the domestic market, looks at the world, leads the development of the industry with scientific and technological innovation, serves a healthy life with scientific concepts, adheres to the original intention, and strives to become a benchmark enterprise in the field of healthy life.

Learn More;

LIST OF STRAINS
Probiotics	Strain Number	Type(CFU/g)
Lactiplantibacillus plantarum	Lp3a	5-500B
Lacticaseibacillus rhamnosus	LR05	5-400B
Lacticaseibacillus casei	LC11	5-400B
Lacticaseibacillus paracasei	LPC45	5-400B
Lactobacillus fermentum	LF021	5-300B
Lactobacillus salivarius	LS01	5-100B
Lactobacillus reuteri	LR06	5-200B
Lactobacillus acidophi/us	LA16	5-200B
Lactobacillus  helveticus	LH030/LZ-R-5	5-200B
Lactobacillus crispatus	LCP051	5-100B
Lactobacillus gasseri	LG021/LG019	5-200B
Lactobacillus johnsonii	LJ10	5-100B
Lactobacillus delbrueckii subsp. bulgaricus	LB45	5-20B
Bifidobacterium animalis subsp. lactis	Bla019	5-400B
Bifidobacterium animalis subsp. animalis	BA023	5-500B
Bifidobacterium breve	BB033	5-200B
Bifidobacterium longum subsp. longum	BL5b	5-100B
Bidobacterium longum subsp. infantis	BI08	5-50B
Bifidobacterium bifidum	BMC31	5-200B
Bifidobacterium adolesentis	BAA021	5-100B
Streptococcus salivarius subsp. thermophilus	ST076	5-300B
Pediococcus pentosaceus	PP016	5-300B
Pediococcus acidolactici	PAL31	5-400B
Leuconostoc mesenteroides subsp. mesenteroides	LCM020	5-200B
Weizmannia  coagulans	BC01	5-100B
Akkermansia  muciniphila	AMP018	5-200B

Related: Lactobacillus plantarum CQPC03/ Lactobacillus plantarum LP3A/ Lactobacillus plantarum FPHC0500